MassMutual Private Wealth & Trust’s Prime Medicine PRME Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio PRME Stock Details PRME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-104	Closed	-$304	–	2456
2024 Q4	$304	Buy	+104	New	+$365	﹤0.01%	2218
2023 Q4	–	Sell	-25	Closed	-$239	–	2060
2023 Q3	$239	Sell	25 -9	-26%	-$117	﹤0.01%	1916
2023 Q2	$498	Buy	+34	New	+$475	﹤0.01%	1782

Other funds holding PRME

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

MassMutual Private Wealth & Trust's PRME Position: Q1 2025 in Review

MassMutual Private Wealth & Trust sold out of Prime Medicine (PRME) in Q1 2025, closing a stake of 104 shares — an estimated $304 sold.

MassMutual Private Wealth & Trust first reported a position in PRME in Q2 2023 and held it in 3 quarters. The position peaked at $498 in Q2 2023. 125 funds tracked by Wall St. Rank hold PRME as of Q1 2025.

MassMutual Private Wealth & Trust reported no remaining Prime Medicine position as of Q1 2025 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 104 Prime Medicine shares in Q1 2025, an estimated $304.
MassMutual Private Wealth & Trust first reported a position in Prime Medicine in Q2 2023 and held it in 3 quarters.
MassMutual Private Wealth & Trust's Prime Medicine position peaked at $498 in Q2 2023.
125 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2025, filed 1 Apr 2025.